Table 4 BLU, RASSF1A and MGMT genes hypermethylation in astrocytoma tumor samples.
BLU | RASSF1A | MGMT | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample | MSP | MCA-MSP | MCA-Meth | MSP | MCA-MSP | MCA-Meth | Seq | MSP | MCA-MSP | MCA-Meth | Seq | ||||
7 | A III | U | U | 0% | U+M | U+M | <5% | U | U+M | U+M | <5% | ||||
8 | A III-IV | U | U | U | 0% | U+M | U+M | U+M | <5% | U+M | U | U+M | <5% | ||
12 | GBM | U | U | U | 0% | U+M | M | U+M | <5% | U | U | U | 14% | ||
13 | GBM | U+M | U+M | U | 22% | U+M | M | U+M | 20% | U | U | U | 0% | ||
26 | GBM | U+M | U | U | 0% | U+M | M | U+M | <5% | U | U | U | 0% | U | |
28 | GBM | U+M | U | U+M | <5% | U+M | M | U+M | 12% | M | U+M | M | 100% | M | |
30 | GBM | U+M | U+M | U+M | 65% | U+M | U+M | U+M | 72% | M | U+M | U+M | UM | ||
33 | A III | U+M | U+M | U+M | 57% | U+M | U+M | U+M | 46% | U+M | U+M | UM | UM | ||
45 | GBM | U | U | U | 0% | U+M | U+M | U+M | <5% | U+M | U | U | 0% | ||
46 | GBM | U | U | U | 0% | U+M | U+M | U+M | <5% | U+M | U | U+M | <5% | ||
47 | A III-IV | U | U | U | 0% | U+M | U+M | U+M | 22% | U+M | U | U+M | <5% | ||
49 | GBM | U | U | U | 0% | U+M | U+M | U+M | <5% | U | U | U | 0% | ||
51 | GBM | U | U | U | 16% | U+M | U+M | U+M | <5% | U+M | U | UM | |||